Pulmatrix Inc (PULM)

[riskon]

$PULM Weekly & Daily Charts & Catalysts -- Bullish Setup

Known Timeline Events
-11/5 Delisting notice needs to be extended to meet $1.00 NASDAQ requirement -- They have already pre-approved R/S if absolutely need-be and have confirmed in recent conversations with the CEO, Dr. Clarke that there is no intention of an R/S in the immediate future.
-11/8 Earnings: Expecting to hear about their cash position, and how they are going to raise funds. If non-dilutitive cash (even if a loan), then this ticker will fly. Potential partnership news?

Other Catalysts & Information:
-1 unidentified CTO filed last year
-The other CTO was revealed to be Glenmark who we are formulating VR410 with, which plans to start clinical in 2019 -- which has broad bullish permutations and potential cash source
-Chinese partnership opportunities mentioned previously yet not followed up upon recently
-Pur1800 phase 2 data results in soon
-Pur1900 phase 2 setup/starting before EOY 2018
-"Steady inbound interest" being fielded for iSperse technology -- always the chance of a buyout -- iSperse is not so much a medication yet rather the best ubiquitous platform to deliver medication to the lungs, most safely and most effectively